Recent studies investigate Phexxi for various potential indications


Bassem Maximos, MD, MPH, FACOG, discusses 2 recent studies investigating nonhormomal contraceptive gel Phexxi (Evofem Biosciences) for the potential treatment of UTIs and improvement in sexual satisfaction.

**Editors note: In an earlier version of this video, Dr. Maximos explained that 77% of women on study/using Phexxi suffered a UTI. The data actually shows that 77 women out of 1339 study subjects suffered a UTI, a notable decrease in UTIs in women using Phexxi. The video has since been edited to reflect this correction.

Related Videos
Learning what women prefer in STI preventive care
Understanding combined oral contraceptives and breast cancer risk | Image Credit:
Why doxycycline PEP lacks clinical data for STI prevention in women
The importance of nipocalimab’s FTD against FNAIT | Image Credit:
Understanding the impact of STIs on young adults | Image Credit:
Revolutionizing menopause management: A deep dive into fezolinetant | Image Credit:
Expert on OAB
Expert on OAB
How to address sexual dysfunction during menopause | Image Credit:
Related Content
© 2024 MJH Life Sciences

All rights reserved.